Pfizer (PFE) stock has attracted fresh attention after recent trading left its one-month return at a 3.3% decline and its ...

Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game.

Now, it’s worth noting Stock Advisor’s total average return is 966 % — a market-crushing outperformance compared to 194% for ...

The S&P 500 wrapped up 2025 with a total return of about 18%, the third straight year above historical norms but a lower ...

Aktis Oncology is aiming to bring in $182 million—or more—from what looks set to be the first biotech IPO of 2026. | Aktis ...

Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases with significant unmet ...

Inside a single-story brick building in Sorrento Mesa is a small lab sprinkled with beakers, test tubes and incubators that ...

Samsung Bioepis is reshaping its distribution and sales. Since 2015, the company has maintained an "indirect sales" system that distributes and sells biosimilar products in global markets such as the ...

The global amyloidosis treatment market is on a trajectory of significant expansion, driven by heightened disease awareness, ...

Both Ford and Pfizer have very attractive dividend yields.

A man who broke windows at Vice President JD Vance’s Ohio home and caused other property damage was detained early Monday, ...

DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...